1. Home
  2. WATT vs SNGX Comparison

WATT vs SNGX Comparison

Compare WATT & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energous Corporation

WATT

Energous Corporation

HOLD

Current Price

$5.97

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.58

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WATT
SNGX
Founded
2012
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
13.8M
IPO Year
2014
1987

Fundamental Metrics

Financial Performance
Metric
WATT
SNGX
Price
$5.97
$1.58
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
45.5K
284.0K
Earning Date
11-12-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,018,000.00
N/A
Revenue This Year
$509.64
N/A
Revenue Next Year
$210.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
600.23
N/A
52 Week Low
$3.67
$1.09
52 Week High
$81.00
$6.23

Technical Indicators

Market Signals
Indicator
WATT
SNGX
Relative Strength Index (RSI) 39.72 54.56
Support Level $5.92 $1.49
Resistance Level $6.77 $1.60
Average True Range (ATR) 0.50 0.13
MACD 0.03 0.04
Stochastic Oscillator 14.18 78.05

Price Performance

Historical Comparison
WATT
SNGX

About WATT Energous Corporation

Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: